Health-related quality of life in clinically isolated syndrome and risk of conversion to multiple sclerosis.


Journal

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 19 04 2018
accepted: 15 09 2018
pubmed: 27 9 2018
medline: 12 3 2019
entrez: 27 9 2018
Statut: ppublish

Résumé

A few studies have found that low scores on self-rated health and quality of life measures are associated with following worsening disability in multiple sclerosis (MS). We wanted to estimate the association between self-rated quality of life scores among patients with clinically isolated syndrome (CIS) and the risk of subsequent conversion to definite MS. One hundred sixty-two patients from the GERONIMUS cohort with a symptom or sign suggestive of MS and without a definite diagnosis of MS at the time of inclusion were asked to evaluate their health-related quality of life according to MSQoL-54 scale. They were clinically assessed and mood and depression scales were applied. The association between the scores of these scales and the risk of converting to definite MS during a 5-year follow-up was estimated using the Cox- proportional hazard regression model. Quality of life at examination was significantly lower compared to those of an age- and sex-adjusted general Italian population. During the follow-up, 116 patients (72%) converted to definite MS. No significant predictive effects were found for the summary scales of MSQol-54 or other scales. The estimates did not change after adjusting for age, sex, BMI, education, MRI findings, Expanded Disability Status Scale (EDSS) score, and treatment at time of examination. Persons with CIS in this cohort reported reduced self-rated quality of life compared to the general population, but variation in these scores was not associated with subsequent conversion from CIS to clinical definite MS.

Sections du résumé

BACKGROUND AND OBJECTIVES OBJECTIVE
A few studies have found that low scores on self-rated health and quality of life measures are associated with following worsening disability in multiple sclerosis (MS). We wanted to estimate the association between self-rated quality of life scores among patients with clinically isolated syndrome (CIS) and the risk of subsequent conversion to definite MS.
METHODS METHODS
One hundred sixty-two patients from the GERONIMUS cohort with a symptom or sign suggestive of MS and without a definite diagnosis of MS at the time of inclusion were asked to evaluate their health-related quality of life according to MSQoL-54 scale. They were clinically assessed and mood and depression scales were applied. The association between the scores of these scales and the risk of converting to definite MS during a 5-year follow-up was estimated using the Cox- proportional hazard regression model.
RESULTS RESULTS
Quality of life at examination was significantly lower compared to those of an age- and sex-adjusted general Italian population. During the follow-up, 116 patients (72%) converted to definite MS. No significant predictive effects were found for the summary scales of MSQol-54 or other scales. The estimates did not change after adjusting for age, sex, BMI, education, MRI findings, Expanded Disability Status Scale (EDSS) score, and treatment at time of examination.
CONCLUSION CONCLUSIONS
Persons with CIS in this cohort reported reduced self-rated quality of life compared to the general population, but variation in these scores was not associated with subsequent conversion from CIS to clinical definite MS.

Identifiants

pubmed: 30255488
doi: 10.1007/s10072-018-3582-0
pii: 10.1007/s10072-018-3582-0
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

75-80

Subventions

Organisme : Biogen Idec
ID : unconditional grant
Organisme : Department of Neurological Sciences of the University of Bologna
ID : NA

Références

J Neurol Neurosurg Psychiatry. 1999 Aug;67(2):158-62
pubmed: 10406981
Neurology. 2000 Jul 12;55(1):51-4
pubmed: 10891905
Ann Neurol. 2001 Jul;50(1):121-7
pubmed: 11456302
Mult Scler. 2003 Jun;9(3):302-6
pubmed: 12814180
Neurol Sci. 2004 Feb;24(6):375-83
pubmed: 14767682
Neurology. 2004 Dec 14;63(11):2046-50
pubmed: 15596748
Lancet Neurol. 2005 Sep;4(9):556-66
pubmed: 16109362
J Rehabil Res Dev. 2006 Jan-Feb;43(1):35-44
pubmed: 16847770
Curr Opin Neurol. 2007 Jun;20(3):269-74
pubmed: 17495619
Mult Scler. 2008 Aug;14(7):999-1002
pubmed: 18505776
Int J Clin Pract. 2012 May;66(5):504-14
pubmed: 22512609
Eur J Neurol. 2013 Jan;20(1):79-86
pubmed: 22742892
Eur J Neurol. 2013 Jun;20(6):907-14, e78-9
pubmed: 23347258
J Neurol. 2013 Jun;260(6):1583-93
pubmed: 23377434
Acta Neurol Belg. 2013 Dec;113(4):403-9
pubmed: 23460394
Neurol Sci. 2015 Jun;36(6):845-52
pubmed: 25638416
Neurology. 1983 Nov;33(11):1444-52
pubmed: 6685237
Qual Life Res. 1995 Jun;4(3):187-206
pubmed: 7613530
J Clin Epidemiol. 1998 Nov;51(11):1025-36
pubmed: 9817120

Auteurs

Elisa Baldin (E)

IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.

Trond Riise (T)

Department of Global Public Health and Primary Care, Bergen University, Bergen, Norway.
The Norwegian Multiple Sclerosis Competence Center, Haukeland University Hospital, Bergen, Norway.

Katia Mattarozzi (K)

Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.

Alberto Gajofatto (A)

Neurology Unit B, University Hospital of Verona, Verona, Italy.

Franco Granella (F)

Department of Medicine and Surgery, University of Parma, Parma, Italy.

Maurizio Leone (M)

SC Neurology, Department of Medical Sciences, IRCCS "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Italy.

Alessandra Lugaresi (A)

Multiple Sclerosis Center, Department of Neuroscience and Imaging, University "G. D'Annunzio", Chieti-Pescara, Italy.

Susanna Malagù (S)

Neurology Unit, "Bufalini" Hospital, Cesena, Italy.

Luisa Motti (L)

Neurology Unit, Arcispedale S. Maria Nuova, Reggio Emilia, Italy.

Walter Neri (W)

Neurology Unit, Multiple Sclerosis Center, G.B.Morgagni-L.Pierantoni Hospital, Forlì, Italy.

Ilaria Pesci (I)

Neurology Unit, AUSL Parma, Fidenza Hospital, Fidenza, Parma, Italy.

Mario Santangelo (M)

Neurology Unit, Ramazzini Hospital, Carpi, Modena, Italy.

Cinzia Scandellari (C)

IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.

Maria Rosaria Tola (MR)

Neurology Unit, Department of Neuroscience, University Hospital of Ferrara, Ferrara, Italy.

Luca Vignatelli (L)

IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.

Corrado Zenesini (C)

IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.

Roberto D'Alessandro (R)

IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy. roberto.dalessandro@ausl.bologna.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH